Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy involving the spleen,
bone marrow, and frequently the blood. SMZL lymphomagenesis involves antigen and/or …

Splenic marginal zone lymphoma (SMZL) is an indolent small B-cell lymphoma involving the
spleen and bone marrow characterized by a micronodular tumoral infiltration that replaces …

Splenic marginal zone lymphoma (SMZL) is an indolent B cell malignancy usually involving
spleen, bone marrow and blood. The disease presents as an incidental finding or with …

Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity.
The clinical course is variable, multiple genes are mutated with no unifying mechanism, and …

Splenic marginal zone lymphoma (SMZL) accounts for less than 2% of all non‐Hodgkin
lymphomas. We identified 107 cases diagnosed with SMZL between 1985 and 2012 from …

Splenic marginal zone lymphoma (SMZL) is a specific low-grade small B-cell lymphoma that
is incorporated in the World Health Organization classification. Characteristic features are …

Splenic marginal zone lymphoma (SMZL) and nodal marginal zone lymphoma (NMZL) are
newly defined, separate clinicopathological entities. Both are rare lymphoma types, with low …

Splenic marginal zone lymphoma (SMZL) is a B-cell neoplasm whose molecular
pathogenesis remains fundamentally unexplained, requiring more precise diagnostic …

Splenic marginal zone lymphoma (SMZL) is an uncommon indolent B-cell lymphoma
causing marked splenic enlargement with CD20-rich lymphoma cells infiltrating blood and …

BACKGROUND The optimal management of patients with splenic marginal zone
lymphoma/marginal zone lymphoma (SMZL) is controversial. The objective of this …